Rosemary D Cress
Affiliation: California Environmental Protection Agency
- Factors associated with initial treatment and survival for clinically localized prostate cancer: results from the CDC-NPCR Patterns of Care Study (PoC1)Maria J Schymura
New York State Cancer Registry, New York State Department of Health, 150 Broadway, Suite 361, Menands, NY 12204 2719, USA
BMC Cancer 10:152. 2010....
- Surgical staging of early stage epithelial ovarian cancer: results from the CDC-NPCR ovarian patterns of care studyRosemary D Cress
California Cancer Registry, Public Health Institute, Sacramento, CA, USA
Gynecol Oncol 121:94-9. 2011....
- Secular changes in colorectal cancer incidence by subsite, stage at diagnosis, and race/ethnicity, 1992-2001Rosemary D Cress
California Cancer Registry, Public Health Institute, Sacramento, 95815, USA
Cancer 107:1142-52. 2006..We evaluated recent trends in colorectal cancer incidence in the United States by subsite and stage at diagnosis...
- Survival among patients with adenocarcinoma of the pancreas: a population-based study (United States)Rosemary D Cress
California Cancer Registry, Public Health Institute, and Department of Public Health Sciences, UC Davis, Sacramento, CA 95815, USA
Cancer Causes Control 17:403-9. 2006..The purpose of the current study was to evaluate survival of patients diagnosed in California with adenocarcinoma of the pancreas by demographic and tumor-related factors...
- Patterns of chemotherapy use for women with ovarian cancer: a population-based studyRosemary D Cress
California Cancer Registry and Division of Gynecologic Oncology, University of California at Davis Medical Center, Sacramento, CA, USA
J Clin Oncol 21:1530-5. 2003..To evaluate adherence to published recommendations for chemotherapy for ovarian cancer patients in the general community and to identify factors associated with its use...
- Completeness of information on adjuvant therapies for colorectal cancer in population-based cancer registriesRosemary D Cress
California Cancer Registry, Sacramento, California 95815, USA
Med Care 41:1006-12. 2003..Population-based cancer registries represent a potentially valuable tool to evaluate treatment; however, information on the completeness of registry treatment data is sparse...
- Incidence of anal cancer in California: increased incidence among men in San Francisco, 1973-1999Rosemary D Cress
California Cancer Registry, Sacramento, CA, USA
Prev Med 36:555-60. 2003..Incidence of anal cancer has increased in the United States during the past 30 years. This report describes the incidence of this rare cancer in the diverse California population...
- Factors associated with time to availability for cases reported to population-based cancer registriesJulie Smith-Gagen
California Cancer Registry, Public Health Institute, 1700 Tribute Road, Ste. 100, Sacramento, CA 95815, USA
Cancer Causes Control 16:449-54. 2005..CONCLUSION: Strategies are needed to improve timeliness without sacrificing quality and completeness...
- Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer RegistryKatrina R Bauer
Public Health Institute California Cancer Registry, Sacramento, California 95815 4402, USA
Cancer 109:1721-8. 2007..The triple-negative phenotype is important because of its relation to the basal-like subtype of breast cancer...
- Declining trends of epithelial ovarian cancer in CaliforniaCyllene R Morris
California Cancer Registry, Public Health Institute, Sacramento, California, USA
Gynecol Oncol 108:207-13. 2008..Known risk factors for ovarian cancer are unequally distributed across different cultures. California, the most ethnically diverse State in the U.S., is uniquely positioned to detect trends in different race/ethnic groups...
- Ovarian cancer: can we make the clinical diagnosis earlier?Lloyd H Smith
Department of Obstetrics and Gynecology, University of California at Davis, School of Medicine, Sacramento, California 95817, USA
Cancer 104:1398-407. 2005..The aim of this study was to provide an objective evaluation of symptoms that precede a diagnosis of ovarian cancer...
- Benefit of postoperative adjuvant therapy for pancreatic cancer: A population-based analysisKimberly A Vanderveen
Department of Surgery, University of California at Davis Cancer Center, Sacramento, California 95817, USA
Cancer 115:2420-9. 2009..In the current study, the authors sought to identify the impact of adjuvant therapy and factors associated with any improvement in survival after resection of pancreatic cancer...
- Risk of cancer among rheumatoid arthritis patients in CaliforniaArti Parikh-Patel
California Cancer Registry, Public Health Institute, 1825 Bell Street, Suite 102, Sacramento, CA 95825, USA
Cancer Causes Control 20:1001-10. 2009..The objective of this retrospective cohort study was to evaluate cancer risk among rheumatoid arthritis (RA) patients in California...
- Does socioeconomic disparity in cancer incidence vary across racial/ethnic groups?Daixin Yin
California Cancer Registry, Public Health Institute, Sacramento, CA 95825, USA
Cancer Causes Control 21:1721-30. 2010....
- Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in CaliforniaArti Parikh-Patel
California Cancer Registry, Public Health Institute, 1700 Tribute Road, Suite100, Sacramento, CA 95815 4402, USA
Cancer Causes Control 19:887-94. 2008..We conducted a retrospective cohort study to examine cancer risk in a large cohort of systemic lupus erythematosus (SLE) patients in California...
- Stage of breast cancer diagnosis among medically underserved women in California receiving mammography through a state screening programDavid H Harris
California Cancer Registry, Cancer Surveillance Section, Public Health Institute, 1700 Tribute Road, Suite 100, Sacramento 95815, USA
Cancer Causes Control 15:721-9. 2004..This study describes breast cancer stage at diagnosis among California women receiving mammograms through a state-administered screening program in comparison to other California women...
- Epithelial ovarian cancer risk by invasiveness and cell type in the Central Valley of CaliforniaPaul K Mills
Public Health Institute, Cancer Registry of Central California, CA 93710 7905, USA
Gynecol Oncol 95:215-25. 2004..To evaluate epithelial ovarian cancer (EOC) risk factors by level of invasiveness and histology...
- Laparoscopic versus abdominal hysterectomy for endometrial cancer: comparison of patient outcomesGary S Leiserowitz
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California, Davis, Medical Center, CA, USA
Int J Gynecol Cancer 19:1370-6. 2009..To compare the demographics, cancer characteristics, and hospital outcomes of endometrial cancer patients undergoing a laparoscopically assisted vaginal hysterectomy (LAVH) versus a total abdominal hysterectomy (TAH)...
- Evidence of poorer survival in pregnancy-associated breast cancerAnne O Rodriguez
University of California Davis Medical Center, Sacramento, CA, USA
Obstet Gynecol 112:71-8. 2008..To compare stage distribution, tumor characteristics, and survival outcome in pregnancy-associated and non-pregnancy-associated breast cancer, and to evaluate pregnancy as a risk factor for mortality in breast cancer...
- Malignant melanoma in pregnancy. A population-based evaluationAnne T O'Meara
Department of Obstetrics and Gynecology, University of California Davis Medical Center, Sacramento, California 95817, USA
Cancer 103:1217-26. 2005..There have been multiple reports that women with high hormone states, such as pregnancy, had thicker tumors and/or a worse prognosis compared with a group of control women...
- Adjuvant Chemotherapy for Patients with Stage III Colon Cancer: Results from a CDC-NPCR Patterns of Care StudyRosemary D Cress
California Cancer Registry, Public Health Institute, Department of Public Health Sciences, Division of Epidemiology, University of California Davis, Sacramento, CA, USA
Clin Med Oncol 3:107-19. 2009..To evaluate adjuvant chemotherapy use for Stage III colon cancer...
- Pregnancy-associated colon and rectal cancer: perinatal and cancer outcomesMary T Dahling
Department of Obstetrics and Gynecology, University of California Davis, School of Medicine, CA, USA
J Matern Fetal Neonatal Med 22:204-11. 2009..Assess the impact of colorectal cancer on maternal and neonatal outcomes...
- Adnexal masses in pregnancy: how often are they malignant?Gary S Leiserowitz
Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California, Davis Medical Center, Sacramento, CA 95817, USA
Gynecol Oncol 101:315-21. 2006..The secondary objective was to determine maternal and perinatal outcomes among these pregnancies...
- Perineal talc exposure and epithelial ovarian cancer risk in the Central Valley of CaliforniaPaul K Mills
Cancer Registry of Central California Public Health Institute, Fresno, CA, USA
Int J Cancer 112:458-64. 2004..10-2.16). Talc use and EOC risk was highest in women with serous invasive tumors (OR = 1.77; CI = 1.12-2.81). This study provides some support for the hypothesis that perineal talc use is associated with an increased risk of EOC...
- Survival difference between non-Hispanic black and non-Hispanic white women with localized breast cancer: the impact of guideline-concordant therapyXiaocheng Wu
Louisiana Tumor Registry, Epidemiology Program, School of Public Health, Louisiana State University Health Sciences Center, New Orleans, LA 70112, USA
J Natl Med Assoc 100:490-8. 2008..This study examined the impact of guideline-concordant therapy on the survival difference between non-Hispanic black (NHB) and non-Hispanic white (NHW) women with localized breast cancer...
- Factors associated with the suboptimal treatment of women less than 55 years of age with early-stage ovarian cancerJohn K Chan
Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco School of Medicine, UCSF Comprehensive Cancer Center, 94143 1702, USA
Gynecol Oncol 108:95-9. 2008..A significant number of young patients with early-stage ovarian cancer did not receive chemotherapy based on standard practice guidelines. We investigated factors associated with the suboptimal treatment in these women...
- Influence of the gynecologic oncologist on the survival of ovarian cancer patientsJohn K Chan
Division of Gynecologic Oncology, Department of Obstetrics, University of California, San Francisco School of Medicine, San Francisco Comprehensive Cancer Center, San Francisco, California 94143 1702, USA
Obstet Gynecol 109:1342-50. 2007..To estimate the influence of gynecologic oncologists on the treatment and outcome of patients with ovarian cancer...
- Survival of Californian women with epithelial ovarian cancer, 1994-1996: a population-based studyCynthia D O'Malley
Northern California Cancer Center, Union City, CA 94587, USA
Gynecol Oncol 91:608-15. 2003..The objective was to identify demographic, clinical, and provider characteristics that might influence cancer survival in a cohort of Northern California women using a population-based cancer registry...
- Patients' perceptions of quality of care for colorectal cancer by race, ethnicity, and languageJohn Z Ayanian
Division of General Medicine and Channing Laboratory, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
J Clin Oncol 23:6576-86. 2005..To identify opportunities for improving care, we evaluated patients' perceptions of the quality of their cancer care by race, ethnicity, and language...
- Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohortJohn Z Ayanian
Division of General Medicine and Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
J Clin Oncol 21:1293-300. 2003..This population-based study was designed to assess use of these treatments in clinical practice...
- The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDSNancy A Hessol
Department of Medicine, University of California, San Francisco, CA 94122, USA
Am J Epidemiol 165:1143-53. 2007..4). The impact of HAART on non-AIDS-defining cancer incidence rates and survival is not uniform, and the mechanism(s) responsible for these differences should be investigated further...
- Triazine herbicides and epithelial ovarian cancer risk in central CaliforniaHeather A Young
The George Washington University School of Public Health and Health Services, Department of Epidemiology and Biostatistics, Washington, DC 20037, USA
J Occup Environ Med 47:1148-56. 2005..We sought to determine whether women with ovarian cancer have increased occupational exposure to triazine herbicides...
- Hormone replacement therapy and invasive and borderline epithelial ovarian cancer riskPaul K Mills
Cancer Registry of Central California, 1320 E Shaw Ave, Suite 160, Fresno, CA 93710, USA
Cancer Detect Prev 29:124-32. 2005..08). The relationship was stronger in women without hysterectomy (OR: 1.66, 95% CI: 1.14-2.41) or tubal ligation (OR: 1.56, 95% CI: 1.08-2.26). In this study, use of HRT is associated with an increased risk of EOC...
- Breast and Prostate Cancer Patterns of CareRosemary Cress; Fiscal Year: 2007..What is learned about treatment quality and completeness can subsequently be used to improve the information in these registries so that they can become a resource for researchers evaluating quality of cancer care. ..